Russell Investments Group Ltd. Boosts Stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
Russell Investments Group Ltd. increased its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 53,455.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,820 shares of the company’s stock after buying an additional 4,811 shares during the […]
Russell Investments Group Ltd. increased its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 53,455.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,820 shares of the company’s stock after buying an additional 4,811 shares during the […]
